CLIENTS

LaMont Aerospace is harnessing microgravity to improve life on earth.  Here are a few investigations LaMont has facilitated utilizing our on-orbit assets:

 

•Texas A&M- “ntraterrestrial Fungus Grown in Space (iFunGIS): Determining alterations in                      metabolic processes and products of a subsurface fungus in microgravity
 

•NASA- Exploiting Alterations in Pathogen Pigmentation to Characterize Physiological and                            Cellular Responses to Spaceflight
•ISS National Lab- Effect of Microgravity on Human Thyroid Carcinoma Cells/Phase-I

•ISS National Lab- Effect of Microgravity on Human Thyroid Carcinoma Cells/Phase-II
 

•ISS National Lab- Effect of Microgravity on Human Thyroid Carcinoma Cells/Phase-III

​

•ISS National Lab- long-term alterations in primary human macrophages/Phase-I
 

•ISS National Lab- long-term alterations in primary human macrophages/Phase-II

​

•ISS National Lab- The gravity dependence of pharmacodynamics: the integration of lidocaine into membranes in microgravity

​

•ISS National Lab/UAA- Tapping Microgravity to Enhance Biofuel Production
 

•UCF- The role of the space environment on vascular endothelial and smooth muscle cell                         processes
 

•NASA/UCLA- The Impact of Microgravity on the Proliferation of Human Neural Stem Cells and derived-Oligodendrocytes
 

•NASA/UCLA- The Impact of Microgravity on the Proliferation of Human Neural Stem Cells and derived-Oligodendrocytes/Phase-II
 

•NiH/Children's Hospital of Philadelphia- Lung Host Defense in Microgravity   
 

•NiH/Children's Hospital of Philadelphia- Lung Host Defense in Microgravity/Phase-II
 

•National Lab- The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells

•National Lab- The effect of microgravity on plasma-osteocalcin

 

•National Lab- The effect of medication changes in microgravity

​

•ISS National Lab/UAA- Tapping Microgravity to Enhance the Biofuel Production/Phase-II
 

•ISS National Lab/Aphios Pharmaceuticals- Use of precision manufactured targeted nanoparticles for orphan and chronic diseases like Alzheimer’s disease in a microgravity environment using green SuperFluids technology

•GSK- Novel protein aggregation/degradation studies in the unique ISS environment provide mechanistic insights relevant to biopharmaceutical development and degenerative diseases
 

•GSK- Novel protein aggregation/degradation studies in the unique ISS environment provide mechanistic insights relevant to biopharmaceutical development and degenerative diseases/Phase-II
 

•SpacePharma- Identify biological mechanisms that affect changes leading to the production of unique tissue, plant or cell based molecular compounds
 

•NiH/UCSF- Microgravity as model for immunological senescence and Its impact on tissue stem cells and regeneration

​

​

​